$63.67
0.811.3%
Last update: Sep 30, 11:27 AM
Bristol-Myers Squibb Co
BMYNYSE
Bristol-Myers Squibb Earnings & Forecasts
Bristol-Myers Squibb (BMY) earnings history, EPS estimates, revenue forecasts and company guidance.
Bristol-Myers Squibb Guidance
Bristol-Myers Squibb (BMY) last issued guidance on July 30, 2026 for fiscal year 2026. The company guided earnings per share in the range of $6.75 - $7, compared to a consensus EPS estimate of $6.31. Bristol-Myers Squibb also guided revenue in the range of $49B - $50B for the period.
Compared to prior guidance, Bristol-Myers Squibb raised its EPS outlook from a previous range of $6.05 - $6.35. On the revenue side, the company raised its revenue forecast from a prior range of $46B - $47.5B.
Bristol-Myers Squibb has issued 16 guidance updates between October 25, 2022 and July 30, 2026. During this period, the company raised its outlook 6 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.72 | $1.61 | $1.44 | $1.71 |
| Revenue | ||||
| Consensus | $12.64B | $12.71B | — | — |
